Cambridge: drug delivery, silicon-based resonators for licensing

Licensing, Collaboration Opportunities

Scientists at the University of Cambridge have developed a new drug delivery method which could improve the ADMET properties of the drug, as well as a p-n junction actuator for the improved production of silicon based resonators.  Both are available for licensing and collaboration through Cambridge Enterprise.

Drug Delivery Methodology

A simple method to produce a drug complex to potentially improve the ADMET properties of the drug, extend its circulatory life and allow it to be released from the complex appropriate stimuli when required.  It is envisaged that this technology could be applied to a wide range of low solubility drugs to treat many conditions and potentially to others which are currently untreatable.

Ref: Sch-2100-07

p-n Junction Actuator

The p-n junction actuator technology allows silicon based resonators to be produced without the need for an included narrow gap.  This would lead to reduced manufacturing costs whilst still allowing integration of the resonator onto a standard CMOS circuit, a feature not possible with standard quartz based resonators.  The actuating element of the resonator is a reverse biased p-n junction manipulated by an electric field.  The inventors are actively seeking potential collaborators to bring this technology to production.

Ref: Ses-1610-06